Facebook
Twitter
LinkedIn
Forward
SAFE OPIOID PRESCRIBING FOR PEDIATRIC PATIENTS
THIS COURSE HAS BEEN APPROVED BY THE WISCONSIN MEDICAL EXAMINING BOARD AS MEETING THE REQUIREMENTS FOR A CONTINUING EDUCATION COURSE ON THE RESPONSIBLE OPIOID PRESCRIBING GUIDELINES PER MED 13.03(3) OF THE WISCONSIN ADMINISTRATIVE CODE
This interactive course addresses minimizing opioid use and safe opioid prescribing for pediatric patients. Participants have multiple opportunities to engage in learning by viewing presentations, working with the clinical cases and receiving immediate feedback, and studying provided educational resources.
PRACTICE GAPS AND NEEDS
There is great variation among pediatric providers in opioid prescribing based on patient-specific demographic characteristics and pain-related diagnoses. Research indicates that approximately 60% of opioid prescriptions dispensed to pediatric patients include more opioids than are needed to treat the acute pain disorder. The rate of total pediatric admissions and PICU admissions related to opioid ingestion have increased by 39% and 35% respectively from 2004 to 2015 in US children’s hospitals. The mortality rate among children and adolescents because of prescription and illicit opioid poisonings have increased, too. Clinical teams are challenged to respond to a growing public health problem in the young related to opioid use.
Target Audience
Pediatricians, physician assistants, nurse practitioners, nurses, pharmacists, social workers, and other healthcare providers who provide care to pediatric patients.
Learning Objectives
As a result of participation in this course, participants will improve ability to:
- Use best practice for safe opioid selection, dosing, duration, and discontinuation in pediatric patients
- Apply techniques to minimize opioid use in pediatric population
- Effectively communicate with patients and families to support safe use, storage, and disposal of prescribed opioids
- Discuss innovative practices for collaborative, patient-centered pain management in pediatric care
Additional Information
Peggy Riley, RN, MN, MPH
Activity Chair
American Family Children’s Hospital/UW Health
Program Director, Pediatric Pain and
Pediatric Palliative Care Programs
Amy Plumb, MD
Associate Professor (CHS)
Department of Pediatrics
University of Wisconsin School of Medicine and Public Health
Hanna Christensen, PharmD, BCPPS
Pediatric Clinical Pharmacist
American Family Children’s Hospital
University of Wisconsin Hospital and Clinics
Ryan Seagren, PharmD, BCPPS
Pediatric Clinical Pharmacist
American Family Children’s Hospital
University of Wisconsin Hospitals and Clinics
Michael Kim, MD
Associate Professor
BerbeeWalsh Department of Emergency Medicine and Pediatrics
University of Wisconsin School of Medicine and Public Health
Marianna Shershneva, MD, PhD
CPD Evaluation and Assessment Specialist
Office of Continuing Professional Development
University of Wisconsin School of Medicine and Public Health
Julie Martinelli, BS
Educational Technology Manager
Office of Continuing Professional Development
University of Wisconsin School of Medicine and Public Health
Jessica A. Stafford Draper, MSN, RN, CPNP
Pediatric Trauma Nurse Practitioner
American Family Children's Hospital
University of Wisconsin School of Medicine and Public Health
Blaise Nemeth, MD, MS
Associate Professor (CHS)
Department of Orthopedics and Rehabilitation
University of Wisconsin School of Medicine and Public Health
Benjamin Walker, MD
Associate Professor, Department of Anesthesiology
University of Wisconsin School of Medicine and Public Health
Director of Pediatric Pain Management
American Family Children's Hospital
FACULTY DISCLOSURE
It is the policy of the University of Wisconsin–Madison ICEP that the faculty, authors, planners, and other persons who may influence content of this CE activity disclose all relevant financial relationships with commercial interests* in order to allow CE staff to identify and resolve any potential conflicts of interest. Faculty must also disclose any planned discussions of unlabeled/unapproved uses of drugs or devices during the educational activity. For this educational activity all conflicts of interests have been resolved and detailed disclosures are listed below:
*The ACCME defines a commercial interest as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests.
In support of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
CREDIT DESIGNATION STATEMENTS
Accreditation Council for Pharmacy Education (ACPE)
A maximum of 2 hours of knowledge-based CE credit can be earned by successfully completing this live activity. Pharmacists should claim only the credit commensurate with the extent of their participation in the activity. CE credit information, based on verification of live attendance and completion of the program assessment and evaluation, will be provided to NABP within 60 days after the activity completion.
2019 Universal Activity Number (UAN) JA0000358-0000-19-090-H01-P
2020 Universal Activity Number JA0000358-0000-20-006-H01-P
American Medical Association (AMA)
The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Nurses Credentialing Center (ANCC)
The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 2 ANCC contact hours, 2 of which are eligible for pharmacotherapeutic contact hours.
The University of Wisconsin–Madison School of Nursing is Iowa Board of Nursing provider 350.
American Psychological Association (APA)
Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibly for the content of the programs.
Successful completion of this CME activity, which includes participation in the activity and individual assessment of and feedback to the learner, enables the learner to earn up to 2.0 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABP MOC credit.
American Board of Pediatrics MOC Credit
Continuing Education Units
The University of Wisconsin–Madison, as a member of the University Continuing Education Association (UCEA), authorizes this program for 0.2 continuing education units (CEUs) or2 hours.
Wisconsin Medical Examining Board Opioid CME
This course has been approved by the Wisconsin Medical Examining Board as meeting the requirements for a continuing education course on the responsible opioid prescribing guidelines per Med 13.03(3) of the Wisconsin Administrative Code.
Course title: Safe Opioid Prescribing for Pediatric Patients
The following instructors have been approved for your course: Various
Number of Credits Approved: 2
Ref # MEB-1089
Available Credit
- 2.00 MOC II
- 2.00 ACPE Pharmacy
- 2.00 AMA PRA Category 1 Credit™
- 2.00 ANCC
- 2.00 APA
Price
This course is offered through University of Wisconsin-Madison.
To take this course you will be redirected to University of Wisconsin-Madison's website. You must login or create an account with University of Wisconsin-Madison in order to complete this activity.
Mocingbird works to provide curated, high quality content to our users. Have a suggestion? Want to partner with us? Get in touch!